Trial intelligence / Profile preview

Curcumin for Premenstrual Syndrome and Dysmenorrhea

IRCT20120718010324N71Phase 3Completed

Sponsor
Tabriz University of Medical Sciences
Start
Sep 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of curcumin in premenstrual syndrome (PMS) and primary dysmenorrhea (PD), sponsored by Tabriz University of Medical Sciences. Started Sep 2022; status: completed.

02

Drugs

curcumin
03

Conditions

premenstrual syndrome (PMS)primary dysmenorrhea (PD)

Beyond the preview

Go deeper on IRCT20120718010324N71.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20120718010324N71.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call